Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases
暂无分享,去创建一个
Steven D Chang | K. Ramchandran | S. Hancock | J. Neal | H. Wakelee | I. Gibbs | M. Hayden Gephart | Michael Lim | S. Soltys | E. Pollom | Gordon Li | Michael Zhang | S. Padda | Adrian J. Rodrigues | A. Rodrigues